MaxCyte Beheer

Beheer criteriumcontroles 2/4

De CEO MaxCyte is Maher Masoud, benoemd in Jan2024, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 890.37K, bestaande uit 50.5% salaris en 49.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.095% van de aandelen van het bedrijf, ter waarde £ 288.99K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.5 jaar en 3.4 jaar.

Belangrijke informatie

Maher Masoud

Algemeen directeur

US$890.4k

Totale compensatie

Percentage CEO-salaris50.5%
Dienstverband CEOless than a year
Eigendom CEO0.09%
Management gemiddelde ambtstermijn1.5yrs
Gemiddelde ambtstermijn bestuur3.4yrs

Recente managementupdates

Recent updates

MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 09
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

May 30
Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

May 10
Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Mar 14
Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 07
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Oct 07
Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Aug 12
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

May 15
MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

May 14
Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Apr 27
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Nov 20
Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Nov 17
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

Jul 25
We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Feb 22
MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Analyse CEO-vergoeding

Hoe is Maher Masoud's beloning veranderd ten opzichte van MaxCyte's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$35m

Mar 31 2024n/an/a

-US$37m

Dec 31 2023US$890kUS$450k

-US$38m

Sep 30 2023n/an/a

-US$37m

Jun 30 2023n/an/a

-US$33m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$791kUS$413k

-US$24m

Compensatie versus markt: De totale vergoeding ($USD 890.37K ) Maher } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 1.02M ).

Compensatie versus inkomsten: De vergoeding van Maher is gestegen terwijl het bedrijf verliesgevend is.


CEO

Maher Masoud (49 yo)

less than a year

Tenure

US$890,365

Compensatie

Mr. Maher Masoud is President, CEO & Executive Director of MaxCyte, Inc. since January 1, 2024 and served as its Head of Global Business Development and Legal Officer since November 2023 and had been its S...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Maher Masoud
Presidentless than a yearUS$890.37k0.095%
£ 288.0k
Douglas Doerfler
Founder26.3yrsUS$3.14m0.32%
£ 959.6k
Douglas Swirsky
Chief Financial Officer1.7yrsUS$1.29mgeen gegevens
Jay Gelfman
Senior Vice President of Operationsless than a yeargeen gegevensgeen gegevens
Ronald Holtz
Executive Vice President of Administration1.7yrsUS$948.33kgeen gegevens
David Sandoval
Senior Vice Presidentless than a yeargeen gegevensgeen gegevens
Thomas Ross
Executive Vice President of Global Sales10.2yrsgeen gegevens0.024%
£ 72.0k
Jack Horgan
Vice President of Corporate Development1.1yrsgeen gegevensgeen gegevens
Jill Mayer
Senior Vice President of Human Resourcesless than a yeargeen gegevensgeen gegevens
J. Thompson
Consultant3.1yrsUS$264.50kgeen gegevens
James Brady
Senior VP of Technical Applications & Customer Support3.3yrsgeen gegevensgeen gegevens
Ali Soleymannezhad
Chief Commercial Officer1.3yrsgeen gegevensgeen gegevens

1.5yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MXCT wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Maher Masoud
Presidentless than a yearUS$890.37k0.095%
£ 288.0k
William Brooke
Independent Non-Executive Director20.7yrsUS$177.24k0.048%
£ 144.9k
Arthur Mandell
Independent Non-Executive Director18.5yrsUS$170.49k0.36%
£ 1.1m
Patrick Balthrop
Independent Non-Executive Director2yrsUS$155.49k0%
£ 0
Richard Douglas
Independent Non-Executive Chairman of the Board6.8yrsUS$190.49k0.095%
£ 288.0k
Stanley Erck
Independent Non-Executive Director19.7yrsUS$162.24k0.24%
£ 713.6k
John Johnston
Independent Non-Executive Director8.8yrsUS$160.49k0.11%
£ 347.3k
Yasir Al-Wakeel
Independent Non-Executive Director3.4yrsUS$238.53k0%
£ 0
Rekha Hemrajani
Independent Non-Executive Director3.4yrsUS$243.03k0%
£ 0
Marcela Maus
Member of Scientific Advisory Board1.7yrsgeen gegevensgeen gegevens
Cenk Sumen
Member of Scientific Advisory Boardless than a yearUS$897.25k0%
£ 0
Oliver Rando
Member of Scientific Advisory Board1.7yrsgeen gegevensgeen gegevens

3.4yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MXCT wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).